Success Metrics

Clinical Success Rate
84.3%

Based on 237 completed trials

Completion Rate
84%(237/281)
Active Trials
46(12%)
Results Posted
62%(148 trials)
Terminated
44(11%)

Phase Distribution

Ph early_phase_1
7
2%
Ph not_applicable
56
14%
Ph phase_1
64
16%
Ph phase_4
133
34%
Ph phase_3
47
12%
Ph phase_2
79
20%

Phase Distribution

71

Early Stage

79

Mid Stage

180

Late Stage

Phase Distribution386 total trials
Early Phase 1First-in-human
7(1.8%)
Phase 1Safety & dosage
64(16.6%)
Phase 2Efficacy & side effects
79(20.5%)
Phase 3Large-scale testing
47(12.2%)
Phase 4Post-market surveillance
133(34.5%)
N/ANon-phased studies
56(14.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.2%

237 of 303 finished

Non-Completion Rate

21.8%

66 ended early

Currently Active

46

trials recruiting

Total Trials

396

all time

Status Distribution
Active(62)
Completed(237)
Terminated(66)
Other(31)

Detailed Status

Completed237
Terminated44
Recruiting31
unknown29
Withdrawn22
Active, not recruiting15

Development Timeline

Analytics

Development Status

Total Trials
396
Active
46
Success Rate
84.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (1.8%)
Phase 164 (16.6%)
Phase 279 (20.5%)
Phase 347 (12.2%)
Phase 4133 (34.5%)
N/A56 (14.5%)

Trials by Status

completed23760%
enrolling_by_invitation41%
recruiting318%
active_not_recruiting154%
not_yet_recruiting123%
terminated4411%
suspended21%
unknown297%
withdrawn226%

Recent Activity

Clinical Trials (396)

Showing 20 of 396 trialsScroll for more
NCT07634393Phase 4

Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

Not Yet Recruiting
NCT07820969Phase 4

Post-op Analgesia of Nail Unit Procedures

Not Yet Recruiting
NCT04629248Phase 3

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Active Not Recruiting
NCT07525791Phase 1

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

Active Not Recruiting
NCT07570173Phase 2

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

Recruiting
NCT05842044Phase 2

NSAID Use After Robotic Partial Nephrectomy

Recruiting
NCT02495077Phase 2

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

Completed
NCT07824258Phase 1

Post-Vasectomy Pain Study

Recruiting
NCT07840183Phase 4

Epidural Analgesia Versus Opioid-sparing Analgesia for Open Ventral Hernia Repair With Transversus Abdominis Release

Recruiting
NCT02711826Phase 1

Treg Therapy in Subclinical Inflammation in Kidney Transplantation

Completed
NCT07803744Phase 1

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Recruiting
NCT06009926Phase 2

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Active Not Recruiting
NCT07750639Phase 4

Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity

Enrolling By Invitation
NCT07821931Phase 4

Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management

Not Yet Recruiting
NCT06043323Phase 2

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Recruiting
NCT07571252Phase 4

Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery

Recruiting
NCT07102641Phase 4

Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies

Active Not Recruiting
NCT05722002Phase 4

Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial

Recruiting
NCT06373978Phase 4

NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow

Recruiting
NCT07710729Phase 1

A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
396